Gene and Biotech Delivery


13 Sept.			11:30 - 13:00



YOUNGINNOVATION
TT.X - Technical Multi-Track with Parallel SYMPOSIA
Gene and Biotech Delivery
Co-organized with Magna Graecia University of Catanzaro in cooperation with SIRTEPS e SITELF Chair: Massimo FRESTA, University Magna Graecia of Catanzaro
The "Gene and Biotech Delivery" section of the conference explores cutting-edge advancements in the methods and technologies used to deliver genetic and biotechnological materials for therapeutic purposes. Enhancing the accuracy, efficacy, and safety of gene delivery systems is the main goal of recent advancements in this field. These advancements include novel vector designs, such as viral and non-viral carriers, which enable efficient and targeted gene transfer. The creation of advanced delivery systems that enhance the stability and release profiles of therapeutic agents is another advancement that has led to the development of more potent treatments for cancer, genetic disorders, and other diseases. These technological advancements are changing the field of biotechnology and gene therapy and opening the door to more targeted and effective interventions in contemporary medicine.
*The symposium is part of the SE.I*
TT.X.I.1 SE.I.19.1	Introductive Keynote Fabiana QUAGLIA - CV University of Naples "Federico II" From Innovation to Application: Non-Viral Approaches for RNA Delivery
TT.X.I.2 SE.I.19.2	Francesca BUFALIERI Sapienza University of Rome, Italy MEX3A/RIG-I axis as a new therapeutic option for the treatment of glioblastoma
TT.X.I.3 SE.I.19.3	Martina VINCENZI - CV University of Rome "La Sapienza" Genetic engineering of probiotics: a new pharmacological tool for inflammatory and obesity-linked disorders
TT.X.I.4 SE.I.19.4	Teresa FERRILLO University of Naples “Federico II” On the role of PEG-Lipids in the development of Lipid nanoparticles for siRNA delivery
TT.X.I.5 SE.I.19.5	Virgilio PICCOLO University of Naples “Federico II” Innovative and smart functionalisable polymeric Nanoparticles for the delivery of Nucleic Acids and Chemotherapeutic in combination for tumor solid treatment